Image

Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run)

Recruiting
65 years of age
Both
Phase N/A

Powered by AI

Overview

Illeteracy concerns more than 38% of Réunion Island's people older than 65 years old, which makes it an important risk factor for dementia and a limit to neurocognitive test's administration.

The MMSRun is a Mini Mental State Examination's version adapted to illeteracy and Réunionese culture, inspired by Hindi Mental State Examination's work. It allows a way better participation during neurocognitive evaluation, but it has never been validated.

This study is a peliminary study to a validation, where the concordance between scores obtained from MMSRun and from the consensual version of Mini Mental State Examination proposed by GRECO (Groupe de Réflexion sur les Evaluations Cognitives) - the only french version validated - on a hospitalized and eldery population will be analyzed.

Eligibility

Inclusion Criteria:

  • Patient who needs a cognitive evaluation by MMSe/MMS-RUN during usual medical care
  • Patient born and living in Réunion Island
  • Patient hospitalized in geriatrics department or in the departement of physical medecine and rehabilitation
  • Patient who agrees to participate in the study and who does not oppose to the use of his data

Exclusion Criteria:

  • Patient with hearing and visual disorder that can interfere in cognitive test administration
  • Patient with altered state of consciousness (Glasgow score different of 15)
  • Patient diagnosed or having symtoms compatible with a psychiatric pathology with psychosis (altered perception of reality)
  • Patient with a current and severe addiction to Alcohol or any other drug (smoking excluded)
  • Patient deprived of liberty by judicial or administrative decision and patient under curatorship or guardianship

Study details

Neurocognitive Deficit

NCT05858489

Centre Hospitalier Universitaire de la Réunion

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.